Targeting hepatic stellate cells to combat liver fibrosis: where do we stand?

被引：5
|
作者：
Breitkopf-Heinlein, Katja [1 ]
Martinez-Chantar, Maria Luz [2 ]
机构：
[1] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Surg, D-68167 Mannheim, Baden Wurttembe, Germany
[2] Ctr Cooperat Res Biosci, Liver Dis Lab, Derio, Spain
来源：
GUT | 2024年 / 73卷 / 09期
关键词：
CELL BIOLOGY; CHRONIC LIVER DISEASE;
D O I：
10.1136/gutjnl-2023-331785
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1411 / 1413
页数：3
相关论文
共 50 条
  • [31] Hepatic stellate cells: a target for the treatment of liver fibrosis
    Wu, J
    Zern, MA
    JOURNAL OF GASTROENTEROLOGY, 2000, 35 (09) : 665 - 672
  • [32] The GAIN Act legislation to combat antimicrobial resistance: Where do we stand?
    Sfeir, Maroun M.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2018, 39 (12): : 1499 - 1500
  • [33] Laurdan in living cells: Where do we stand?
    Vargas-Velez, L. Stefania
    Wilke, Natalia
    CHEMISTRY AND PHYSICS OF LIPIDS, 2025, 266
  • [34] Pituitary stem cells: Where do we stand?
    Vankelecom, Hugo
    Chen, Jianghai
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2014, 385 (1-2) : 2 - 17
  • [35] Melanoma initiating cells: where do we stand?
    Villani, Vincenzo
    Sabbatino, Francesco
    Ferrone, Cristina R.
    Ferrone, Soldano
    MELANOMA MANAGEMENT, 2015, 2 (02) : 109 - 114
  • [36] Where do we stand?
    Thompson, ID
    FORESTRY CHRONICLE, 2003, 79 (03): : 381 - 382
  • [37] Where do we stand?
    不详
    INTERNATIONAL JOURNAL OF PRODUCTIVITY AND PERFORMANCE MANAGEMENT, 2010, 59 (03) : 79 - 86
  • [38] Where do we stand?
    Catt, Graham
    AUSTRALIAN VETERINARY JOURNAL, 2008, 86 (07) : N8 - N8
  • [39] WHERE DO WE STAND?
    Stolper, Gustav
    HARVARD BUSINESS REVIEW, 1931, 9 (03) : 289 - 298
  • [40] WHERE DO WE STAND
    MCMILLAN, B
    IRE TRANSACTIONS ON INFORMATION THEORY, 1957, 3 (03): : 173 - 174
12345